Literature DB >> 16097542

Total hip arthroplasty in Denmark: incidence of primary operations and revisions during 1996-2002 and estimated future demands.

Alma B Pedersen1, Søren P Johnsen, Søren Overgaard, Kjeld Søballe, Henrik T Sørensen, Ulf Lucht.   

Abstract

BACKGROUND: The annual number of total hip arthroplasties (THA) has increased in Denmark over the past 15 years. There is, however, limited detailed data available on the incidence of THAs.
METHODS: We calculated the incidence rates (IR) of primary THA and revision in Denmark between 1996 and 2002 and estimated the demands for primary THA in Denmark until 2020. We used data from the Danish Hip Arthroplasty Registry, a nationwide and population-based clinical database, to identify patients who had undergone primary THA (n = 37,144) or revision arthroplasties (n = 6446). Age and sex-specific data on the Danish population were obtained from the StatBank Denmark. All IRs were standardized according to two standards, i.e. the Danish population in 1996 and the European standard population (18 age groups). The future demands for primary THA were estimated using the age and sex-specific incidence of primary THA for 2002 as a reference, and taking into account the expected changes in the age distribution of the population and the trend in IRs seen in Denmark between 1996 and 2002.
RESULTS: The annual overall standardized IRs of primary THAs and revisions increased from 101 (95% confidence interval (CI): 97.6-104) to 134 (CI: 131-138) and from 19.2 (CI: 17.9-20.5) to 21.1 (CI: 19.8-22.4) per 100,000 inhabitants from 1996 to 2002, respectively (IRs adjusted to the Danish population in 1996). The IRs of primary THAs and revisions increased by 30% and 10% during this period. The relative increase in IRs of primary THAs was found to be similar in both women and men. The increase was higher among patients aged 50-59 years, however. Furthermore, a decrease in IRs was seen in patients who underwent primary THA due to rheumatoid arthritis. IRs of primary THAs have been estimated to increase by 22% in 2020 compared with 2002, based only on the expected changes in the age distribution of the population. However, assuming that the annual age and sex-independent increase in the IRs seen in the period 1996-2002 will continue, the IR of primary THA is estimated to increase by as much as 210% in 2020.
INTERPRETATION: The overall annual standardized IRs of primary THAs and revisions in Denmark increased during the period from 1996 to 2002. Moreover, the demands for THA procedures in the coming decades may exceed the current capacity due to the ageing population and a continued age and sex-independent increase in surgical activity.

Entities:  

Mesh:

Year:  2005        PMID: 16097542     DOI: 10.1080/00016470510030553

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  25 in total

1.  Revision hip arthroplasty using a cementless modular tapered stem.

Authors:  Christophe Pattyn; Alexander Mulliez; René Verdonk; Emmanuel Audenaert
Journal:  Int Orthop       Date:  2011-06-24       Impact factor: 3.075

Review 2.  Changing incidence of orthopedic surgery in rheumatic disease: contributing factors.

Authors:  Elana J Bernstein; Lisa A Mandl
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

3.  Variation in rheumatoid hand and wrist surgery among medicare beneficiaries: a population-based cohort study.

Authors:  Lin Zhong; Kevin C Chung; Onur Baser; David A Fox; Huseyin Yuce; Jennifer F Waljee
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

4.  Effects of gold coating on experimental implant fixation.

Authors:  Kasra Zainali; Gorm Danscher; Thomas Jakobsen; Stig S Jakobsen; Jørgen Baas; Per Møller; Joan E Bechtold; Kjeld Soballe
Journal:  J Biomed Mater Res A       Date:  2009-01       Impact factor: 4.396

5.  Epidemiology of knee and hip arthroplasty: a systematic review.

Authors:  Jasvinder A Singh
Journal:  Open Orthop J       Date:  2011-03-16

6.  Improved results of primary total hip replacement.

Authors:  Bjørg-Tilde S Fevang; Stein A Lie; Leif I Havelin; Lars B Engesaeter; Ove Furnes
Journal:  Acta Orthop       Date:  2010-12       Impact factor: 3.717

Review 7.  New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.

Authors:  Ola E Dahl
Journal:  Vasc Health Risk Manag       Date:  2012-01-25

8.  Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study.

Authors:  Alma B Pedersen; Frank Mehnert; Soren Overgaard; Soren P Johnsen
Journal:  BMC Musculoskelet Disord       Date:  2009-12-29       Impact factor: 2.362

Review 9.  The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence.

Authors:  Rozalia Dimitriou; George I Mataliotakis; Giorgio Maria Calori; Peter V Giannoudis
Journal:  BMC Med       Date:  2012-07-26       Impact factor: 8.775

10.  Multiple Acetabular Revisions in THA - Poor Outcome Despite Maximum Effort.

Authors:  O Bischel; J B Seeger; Jb Seeger; M Krüger; M Krüge; R G Bitsch; Bg Bitsch
Journal:  Open Orthop J       Date:  2012-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.